SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023771
Filing Date
2017-11-14
Accepted
2017-11-14 16:18:45
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q3 evok-10q_20170930.htm 10-Q 931181
2 EX-31.1 evok-ex311_6.htm EX-31.1 9583
3 EX-31.2 evok-ex312_8.htm EX-31.2 9865
4 EX-32.1 evok-ex321_9.htm EX-32.1 5034
5 EX-32.2 evok-ex322_7.htm EX-32.2 5251
  Complete submission text file 0001564590-17-023771.txt   3669428

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20170930.xml EX-101.INS 770422
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20170930.xsd EX-101.SCH 32517
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20170930_cal.xml EX-101.CAL 18250
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20170930_def.xml EX-101.DEF 118829
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20170930_lab.xml EX-101.LAB 236095
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20170930_pre.xml EX-101.PRE 189205
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 171201677
SIC: 2834 Pharmaceutical Preparations